跳至主要内容
临床试验/NCT00276445
NCT00276445终止4 期

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan - A Double-Blind Randomized Study

Meiji University of Oriental Medicine2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2004年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
终止
发起方
入组人数
60
试验地点
2
主要终点
Symptoms were assessed clinically by score on a allergic symptom rating scale.

研究概览

简要总结

Intravenous- injection of beta-1,3-glucan in human is known to induce T helper type 1 response, while oral uptake did not. It was examined whether superfine dispersed beta-1,3-glucan (SDG) contrived to absorbed by intestinal mucosa would alleviate allergic symptoms by per-oral ingestion

详细描述

Beta-1,3-glucan made from Japanese mushroom is commercially available for healthy foodstuffs. Allergy patients were orally administrated either SDG (n=30) or non-dispersed beta-1,3-glucan (NDG, n=30) and allergic symptoms were assessed clinically, by the double-blind, placebo-controlled, randomized study

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • history of seasonal allergic conjunctivitis with or without rhinitis in spring (Japanese cedar pollen season) every year
  • positive allergen specific IgE (> 30 IU/ml) or positive skin prick test result (wheal diameter > 3mm) to Japanese cedar, Orchard Grass pollen, or house dust-mite extract

排除标准

  • Patients who had undergone immunotherapy in the previous 5 years
  • a history of other immunological or medically relevant diseases

结局指标

主要结局

Symptoms were assessed clinically by score on a allergic symptom rating scale.

次要结局

  • Total IgE and allergen specific IgE were measured.
  • The binding capacity of beta-1,3-glucan to peripheral CD14+ cells were assessed.

研究者

发起方
Meiji University of Oriental Medicine
申办方类型
Other

研究点 (2)

Loading locations...

相似试验